AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03314142 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bread enriched with coarse wheat bran
Description: Ten subjects (male: 7, female: 3) consumed 50g available carbohydrates from bread enriched with coarse wheat bran along with 250ml water, tested once, in different weeks, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT03604744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Psilocybin 15 mg per os, single dose
Study NCT03314142 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bread enriched with fine wheat bran
Description: Ten subjects (male: 7, female: 3) consumed 50g available carbohydrates from bread enriched with fine wheat bran (obtained by milling of the coarse bran) along with 250ml water, tested once, in different weeks, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT03314142 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bread enriched with fine wheat bran and carob seed flour
Description: Ten subjects (male: 7, female: 3) consumed 50g available carbohydrates from bread enriched with fine wheat bran (obtained by milling of the coarse bran) in which 10% of the flour was substituted with carob seed flour (CSFB) along with 250ml water, tested once, in different weeks, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min.
Study NCT03172208 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo sc (multiple-dose)
Description: Once daily subcutaneous (sc) administration of Placebo during 7 consecutive days
Study NCT01766856 — intervention group
Intervention type: OTHER
Intervention: Eustachian tube function testing
Description: Eustachian tube function testing will consist of some or all of the following tests: Inflation/Deflation test, Forced Response test, Compliance test,Valsalva, Toynbee and Sniffing
Study NCT03679962 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Triple Chronotherapy
Description: Day 0: One night of total sleep deprivation. The first 24 hours are spent with 1:1 nursing care for provision of comfort measures to stimulate wakefulness and to encourage completion of the intervention.~Day 1-4: Sleep phase advancement Day 1: Sleep from 6 PM to 1 AM Day 2: Sleep from 8 PM to 3 AM Day 3: Sleep from 10 PM and 5 AM Day 4: Awaken at 5 AM; discharge following light therapy~On days 1-4 patients will receive bright light therapy at 7am to 7:30am using a 10,000 Verilux light box. At discharge patients will be given a light box, strongly advised to continue the maintenance sleep schedule and bright light therapy at 7am daily for 30 minutes. Patients will be scheduled for follow-up appointments at 1-week, 1-month and 2-month following discharge.
Study NCT03679962 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: Normal inpatient care, including pharmacotherapy, psychotherapy, milieu therapy and social work interventions
Study NCT00100659 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pegylated Interferon/ribavirin
Study NCT00100659 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pegylated Interferon/ribavirin
Study NCT02718118 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dysport reconstituted at 1.5 mL (0.05 mL/injection)
Description: Subjects treated for moderate to severe (GLSS = 2 or 3) glabellar lines at maximum frown.
Study NCT02718118 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dysport reconstituted at 2.5 mL (0.08 mL/injection)
Description: Subjects treated for moderate to severe (GLSS = 2 or 3) glabellar lines at maximum frown.
Study NCT02555644 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy
Study NCT00678106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalbavancin
Description: Subjects weighing > 60 Kg: 1 gram IV single dose Subjects weighing \< 60 Kg: 15 mg/Kg IV
Study NCT02801630 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PainShield SAW Patch Device
Description: The PainShield is a self contained Surface Acoustic Wave device, where the waves are delivered locally through a trasnducer embedded into a patch that sits on the affected area.
Study NCT02801630 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: PainShield SAW Patch Device
Description: The PainShield is a self contained Surface Acoustic Wave device, where the waves are delivered locally through a trasnducer embedded into a patch that sits on the affected area.
Study NCT02575079 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Parafilm
Description: Single-use, pre-cut sections of parafilm over the central venous catheter (CVC) hub (if not connected) or around the CVC hub connection (if connected). Parafilm will be maintained on the CVC until it is removed.
Study NCT01680419 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mission Reconnect
Description: Multimedia package (audio, video, and print, web-based and downloadable to mobile devices) comprising an integrated program of (1) guided mind/body stress reduction and relaxation practices, (2) contemplative practices to engender and support appreciation, empathy and forgiveness for oneself and one's loved ones, and (3) video instruction in use of simple massage techniques with a partner for connection and stress reduction.
Study NCT01680419 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mission Reconnect
Description: Multimedia package (audio, video, and print, web-based and downloadable to mobile devices) comprising an integrated program of (1) guided mind/body stress reduction and relaxation practices, (2) contemplative practices to engender and support appreciation, empathy and forgiveness for oneself and one's loved ones, and (3) video instruction in use of simple massage techniques with a partner for connection and stress reduction.
Study NCT03604744 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Psilocybin
Description: Psilocybin 15 mg per os, single dose
Study NCT03604744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Psilocybin 30 mg per os, single dose
Study NCT03604744 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Psilocybin
Description: Psilocybin 30 mg per os, single dose
Study NCT01680419 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PREP
Description: The Army's PREP for Strong Bonds program offers retreats for partnered soldiers to support reintegration and healthy relationships. PREP (Prevention and Relationship Enhancement Program) for Strong Bonds is a standardized, evidence-based program conducted in a weekend residential retreat format with experiential exercises. The Army Chaplain Corps trains chaplains to facilitate the program. The manualized program uses methods from cognitive behavioral therapy and communication-oriented marital enhancement programs developed by Markman et al. at the Denver University Center for Marital and Family Studies. Topics include communication, conflict management, commitment, friendship, sensuality, problem-solving, and emotional supportiveness, among others.
Study NCT01742468 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: long-chain n-3 PUFA
Description: Dietary supplement: n-3 LC-PUFA = Microalgae oil (Schizochytrium sp., Maris DHA oil, no. 3790, IOI, Hamburg, Germany (rich in docosahexaenoic acid (DHA)); Dosage: 8 g oil per day = 2.11 g DHA per day; Dosage form: included in 60 g sausage, 8 g tomato spread, 30 g milk powder
Study NCT01742468 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: sunflower oil
Description: Dietary supplement: sunflower oil Name: sunflower oil (PPM, Magdeburg, Germany); Dosage: 8 g per day; Dosage form: 8g oil was included in 60 g sausage, 8 g tomato spread, 30 g milk powder
Study NCT02541838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle power
Study NCT02541838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: balance perturbation
Study NCT02541838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise
Study NCT00828087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus Eluting Coronary Stent System
Description: Everolimus Eluting Coronary Stent System (Everolimus Arm) implantation
Study NCT00828087 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: cobalt chromium balloon expandable stent ( non drug eluting stent Arm)
Description: cobalt chromium balloon expandable stent ( non drug eluting stent Arm)implantation
Study NCT01512641 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Primary stage
Description: Kiddie-Schedule for Affective Disorders and Schizophrenia
Study NCT01512641 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Secondary stage
Description: children who are positive to the kiddie-SADS (primary stage), will take the tests: PANSS, Scale for the Assessment of Negative Symptoms (SANS), ADI-R, scale TLC and WISC IV
Study NCT00771030 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Brodalumab
Description: Solution for subcutaneous or intravenous administration
Study NCT00771030 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Solution for subcutaneous or intravenous administration
Study NCT02578745 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prophylactic NPWT (PICO system)
Description: The PICO NPWT system is a small, lightweight (\~126 grams), portable suction device consisting of an electric motor-driven vacuum pump connected to a proprietary super-absorbent adhesive dressing. It is supplied as a pump with two sterile dressing kits and two batteries. Different dressing sizes are available for transverse and vertical incisions ranging from 10 to 40 cm. The PICO pump maintains negative pressure of -80 mmHg (+/-20 mmHg) to the wound surface.
Study NCT02578745 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Dressing
Description: Standard wound dressing consists of routine postoperative wound dressing consisting of layers of gauze and adhesive tape.
Study NCT04759534 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: protein convertase subtilisin/kexin type 9 inhibitor
Description: IBI306 is a kind of protein convertase subtilisin/kexin type 9 inhibitor.Received abdominal subcutaneous injection of IBI306 150 mg Q2W or 300 mg Q4W
Study NCT04759534 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: protein convertase subtilisin/kexin type 9 inhibitor
Description: IBI306 is a kind of protein convertase subtilisin/kexin type 9 inhibitor.Received abdominal subcutaneous injection of IBI306 150 mg Q2W or 300 mg Q4W
Study NCT01114997 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: Pre-Induction: Lidocaine Loading: 1 mg/kg After Induction:Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Study NCT01114997 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esmolol
Description: Esmolol Pre-Induction: Loading dose 750 mcg/Kg (0.75 mg/kg) Esmolol Post Induction: Infusion dose 7.5 - 15 mcg /kg/min
Study NCT01114997 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine + Esmolol (Combo)
Description: Pre-induction: Lidocaine Loading dose(1 mg/kg) + Esmolol Loading dose(750 mcg/Kg)~Maintenance Infusion rate after Induction:~Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Study NCT00425555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panobinostat
Study NCT01570712 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HOUSING FIRST PROGRAM
Description: Realization of a psychosocial organic evaluation and a citizen;~* Support in the development and the maintenance of the housing;~* Support in the diverse steps (administrative, judicial, financiers, etc.);~* Support around addictions / alcohol;~* Supportin the family and social relations, in the environment of the person -to favor the occupational integration, by prioritizing the insertion in ordinary environment(middle)~* to favor the access and the preservation of the patient to the psychiatric and somatic care, to the devices and the departments favoring the social insertion and the integration.
Study NCT01570712 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional French services
Description: The person will not receive from intervention of the team of site, but the person can resort(turn) without limitation to all the range of services said  about common law  set up in the direction of the persons homeless persons, as well as to every type of care. She can too reach the housing and\\or the restoring, but this by means of the existing devices
Study NCT04462718 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiofrecuency
Description: EXPERIMENTAL GROUP: After the initial evaluation, the first 10 treatment sessions will be developed at the rate of five daily sessions in the first week, three sessions on alternate days in the second week and two sessions on alternate days in the third week (3 weeks in total), applying the monopolar capacitive diathermy with radiofrequency in the anterior aspect of the knee, in dynamic application in one of the members: affect or randomized (uni or bilateral pathology, respectively). This diathermy will be combined with a therapeutic exercise program supervised by a Physiotherapist.
Study NCT04462718 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic Exercise
Description: CONTROL GROUP: will be provided exclusively therapeutic exercises protocol to develop in the home setting that you must perform following a daily activity for three weeks. They will be evaluated at the end of that period and six moths later in order to have at least three timepoints to evaluate.
Study NCT03057834 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle exercise
Description: Standardized pelvic floor muscle exercise regimen
Study NCT03057834 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Pelvic floor muscle exercise
Description: Standardized pelvic floor muscle exercise regimen
Study NCT03121872 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Root Coverage Surgery with T-PRF
Description: Root surfaces in the multiple gingival recession regions were made smooth using Gracey curettes. To remove the smear layer, 24% EDTA solution was applied to the tooth surfaces for approximately 2 minutes and then washed with physiological saline. The receiver region was prepared using the modified tunnel method. After passive stabilization of the flap in the coronal aspect, the preparation of the donor region was initiated
Study NCT03121872 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Root Coverage Surgery with CTG
Description: Root surfaces in the multiple gingival recession regions were made smooth using Gracey curettes. To remove the smear layer, 24% EDTA solution was applied to the tooth surfaces for approximately 2 minutes and then washed with physiological saline. The receiver region was prepared using the modified tunnel method. After passive stabilization of the flap in the coronal aspect, the preparation of the donor region was initiated
Study NCT04332029 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT + WGP + CM
Description: The intervention will be implemented in 8-week group-based sessions and includes: 1) A Cognitive Behavioral Treatment (CBT) for smoking cessation with quit date occurring at sixth session. Patients will be asked to reduce their nicotine intake gradually (i.e., 20% each week); 2) A Weight Gain Prevention module (WGP) which will consist on providing CBT and Dialectical-Behavioral Therapy (DBT) techniques targeting weight stability and associated disordered eating, and 3) a Contingency Management procedure reinforcing smoking abstinence. This component will consist on providing vouchers to reinforce abstinence contingent on biochemical verification. The schedule will incorporate an increasing magnitude of reinforcement.
Study NCT04332029 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT + WGP
Description: The intervention will be implemented in 8-week group-based sessions and will include only the first two components of the experimental intervention: 1) A Cognitive Behavioral Treatment (CBT) for smoking cessation with quit date occurring at sixth session. Patients will be asked to reduce their nicotine intake gradually (i.e., 20% each week); 2) A Weight Gain Prevention module (WGP) which will consist on providing CBT and Dialectical-Behavioral Therapy (DBT) techniques targeting weight stability and associated disordered eating.
Study NCT02223221 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: IVF/ICSI
Description: In vitro fertilization or intracytoplasmic sperm injection.
Study NCT02223221 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IVF/ICSI
Description: In vitro fertilization or intracytoplasmic sperm injection.
Study NCT02223221 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: PGS
Description: Selection of embryos are based on SNP-array-based preimplantation genetic screening for the number of all chromosomes on the 5th day of IVF/ICSI.
Study NCT02223221 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Without PGS
Description: Selection of embryos are based on morphology criteria on the 5th day of IVF/ICSI.
Study NCT01506778 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tenaculum
Description: Single tooth tenaculum are use to the cervix for steady the cervix, straighten the cervicouterine angle and provide countertraction. Most of gynecological office procedure such as endometrial sampling procedure, hysterosalpingography, hysteroscopy, insertion of contraceptive intrauterine device, difficult intrauterine insemination or embryo transfer procedures often require the application of a tenaculum.
Study NCT03828006 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Red Rice Yeast
Description: Participants will take one tablet per day of a dietary supplement based on red rice yeas for a period of six months
Study NCT03828006 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Group
Description: Participants of this group will take one tablet of placebo per day for a period of six months
Study NCT03967158 — intervention group
Intervention type: DEVICE
Intervention: Xience Sierra stent
Description: Percutaneous coronary intervention with Xience Sierra stent
Study NCT01250327 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Melody
Description: insertion of a pulmonic valved stent
Study NCT03468192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-precaution group
Description: Patients in the NPG had no restrictions on mobility, i.e. they were encouraged to move freely during the recovery phase and assistive equipment were prescribed only if needed
Study NCT03195673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terazosin
Description: TZ 0.5mg once a day for 3-7 days before carotid artery stenting to 30 days later.
Study NCT03195673 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Description: Carotid artery stenting is an alternative treatment of carotid artery stenosis, which would be performed by experienced neuroradiologist according to the latest guideline from American Heart Association and American Stroke Association.
Study NCT03195673 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Carotid artery stenting
Description: Carotid artery stenting is an alternative treatment of carotid artery stenosis, which would be performed by experienced neuroradiologist according to the latest guideline from American Heart Association and American Stroke Association.
Study NCT03066934 — intervention group
Intervention type: OTHER
Intervention: noninvasive ventilation respiratory support
Study NCT05440695 — intervention group
Intervention type: DEVICE
Intervention: Continuous non-invasive arterial pressure (Infinity® CNAPTM, Dräger)
Description: The basic working principle of CNAP is to keep the blood volume of the finger arteries constant by applying an exterior pressure to the vessel wall, that is done by an electronic system controlling the pressure inside a cuff around the finger. The pressure in the cuff, which is needed to keep the volume constant during arterial pulsation, corresponds to the AP.
Study NCT03015857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: phenylephrine
Description: - phenylephrine; a vasopressor drug given to prevent post spinal hypotension
Study NCT03015857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine
Description: - norepinephrine; a vasopressor drug given to prevent post spinal hypotension
Study NCT03015857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: intrathecal bupivacaine 10 mg will be given in both groups
Study NCT03015857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: intrathecal fentanyl 20 mcg will be given in both groups
Study NCT03015857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (normal saline)
Study NCT03558087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab 360mg will be administered on Day 1 of each 21 day cycle for four 21-day cycles. Based on response and a balanced patient-physician discussion, subjects may receive nivolumab 240 mg for 8 cycles (cycle = 14 days).
Study NCT03558087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine 1000mg/m\^2 will be administered on Days 1 and 8 for four 21-day cycles.
Study NCT03558087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 70mg\^m2 will be administered on Day 1 for four 21-day cycles.